Last reviewed · How we verify

NCT04282863

Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)

Status unknown NA Last updated 25 February 2020
What this trial tests

NA trial testing RM in Uterine Leiomyoma in 494 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
28 February 2022
28 February 2024

Quick facts

Lead sponsorTaipei Medical University Shuang Ho Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment494
Start date1 March 2020
Primary completion28 February 2022
Estimated completion28 February 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University Shuang Ho Hospital

Who can join

20 and older, female only, with Uterine Leiomyoma or Surgical Procedure, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-blinded RCT evaluating the effect of robotic-assisted (RM) or conventional laparoscopic surgery (LM) in the management of uterine leiomyomas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of RM

Trials testing the same drug.

Other Taipei Medical University Shuang Ho Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04282863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing